No Data
No Data
Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data
Trending Stocks Today | Silexion Therapeutics Shoots up 79.66% Pre-Market
Express News | Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet
Unlock the Full List